Literature DB >> 23179853

Formation of embryoid bodies from human pluripotent stem cells using AggreWell™ plates.

Jennifer Antonchuk1.   

Abstract

Many human embryonic stem (hES) and induced pluripotent stem (hiPS) cell differentiation protocols begin with the formation of three-dimensional aggregates of cells called embryoid bodies (EBs). Traditional EB formation methods result in a heterogeneous population of EB sizes and shapes, which then undergo heterogeneous differentiation efficiencies. AggreWell(TM)400 and AggreWell(TM)800 use the spin-EB method to force the aggregation of a defined number of cells, thereby controlling EB size and generating a population of uniform EBs. Moreover, the dense array of microwells on the bottom surface of AggreWell(TM)400 provide for the rapid and simple production of thousands of EBs at a time.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23179853     DOI: 10.1007/978-1-62703-128-8_32

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  15 in total

1.  Induced pluripotent stem cells for the treatment of recessive dystrophic epidermolysis bullosa.

Authors:  Stavros Spiliopoulos; Nikolaos Davanos
Journal:  Ann Transl Med       Date:  2015-12

2.  Differentiation of Atrial Cardiomyocytes from Pluripotent Stem Cells Using the BMP Antagonist Grem2.

Authors:  Jeffery B Bylund; Antonis K Hatzopoulos
Journal:  J Vis Exp       Date:  2016-03-10       Impact factor: 1.355

3.  Tracking and Predicting Human Somatic Cell Reprogramming Using Nuclear Characteristics.

Authors:  Kaivalya Molugu; Ty Harkness; Jared Carlson-Stevermer; Ryan Prestil; Nicole J Piscopo; Stephanie K Seymour; Gavin T Knight; Randolph S Ashton; Krishanu Saha
Journal:  Biophys J       Date:  2019-10-22       Impact factor: 4.033

4.  Forced aggregation and defined factors allow highly uniform-sized embryoid bodies and functional cardiomyocytes from human embryonic and induced pluripotent stem cells.

Authors:  Martin Pesl; Ivana Acimovic; Jan Pribyl; Renata Hezova; Aleksandra Vilotic; Jeremy Fauconnier; Jan Vrbsky; Peter Kruzliak; Petr Skladal; Tomas Kara; Vladimir Rotrekl; Alain Lacampagne; Petr Dvorak; Albano C Meli
Journal:  Heart Vessels       Date:  2013-11-21       Impact factor: 2.037

5.  Heme degradation enzyme biliverdin IXβ reductase is required for stem cell glutamine metabolism.

Authors:  Zongdong Li; Natasha M Nesbitt; Lisa E Malone; Dimitri V Gnatenko; Song Wu; Daifeng Wang; Wei Zhu; Geoffrey D Girnun; Wadie F Bahou
Journal:  Biochem J       Date:  2018-03-29       Impact factor: 3.857

6.  Multicellular Tumor Spheroids in Nanomedicine Research: A Perspective.

Authors:  Martina Rossi; Paolo Blasi
Journal:  Front Med Technol       Date:  2022-06-15

7.  Properties of neurons derived from induced pluripotent stem cells of Gaucher disease type 2 patient fibroblasts: potential role in neuropathology.

Authors:  Ying Sun; Jane Florer; Christopher N Mayhew; Zhanfeng Jia; Zhiying Zhao; Kui Xu; Huimin Ran; Benjamin Liou; Wujuan Zhang; Kenneth D R Setchell; Jianguo Gu; Gregory A Grabowski
Journal:  PLoS One       Date:  2015-03-30       Impact factor: 3.240

Review 8.  Advances in 3D cell culture technologies enabling tissue-like structures to be created in vitro.

Authors:  Eleanor Knight; Stefan Przyborski
Journal:  J Anat       Date:  2014-11-20       Impact factor: 2.610

9.  Human COL7A1-corrected induced pluripotent stem cells for the treatment of recessive dystrophic epidermolysis bullosa.

Authors:  Vittorio Sebastiano; Hanson Hui Zhen; Bahareh Haddad; Bahareh Haddad Derafshi; Elizaveta Bashkirova; Sandra P Melo; Pei Wang; Thomas L Leung; Zurab Siprashvili; Andrea Tichy; Jiang Li; Mohammed Ameen; John Hawkins; Susie Lee; Lingjie Li; Aaron Schwertschkow; Gerhard Bauer; Leszek Lisowski; Mark A Kay; Seung K Kim; Alfred T Lane; Marius Wernig; Anthony E Oro
Journal:  Sci Transl Med       Date:  2014-11-26       Impact factor: 19.319

10.  Imprinted expression in cystic embryoid bodies shows an embryonic and not an extra-embryonic pattern.

Authors:  Tomasz M Kulinski; M Rita T Casari; Philipp M Guenzl; Daniel Wenzel; Daniel Andergassen; Anastasiya Hladik; Paul Datlinger; Matthias Farlik; H-Christian Theussl; Josef M Penninger; Sylvia Knapp; Christoph Bock; Denise P Barlow; Quanah J Hudson
Journal:  Dev Biol       Date:  2015-04-24       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.